A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - Human vaccines & …, 2014 - Taylor & Francis
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

[HTML][HTML] A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza …

G Della Cioppa, U Nicolay, K Lindert… - Human Vaccines & …, 2014 - ncbi.nlm.nih.gov
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

[PDF][PDF] A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - HUMAN VACCINES …, 2014 - biblio.ugent.be
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - Human Vaccines & …, 2014 - europepmc.org
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - Human vaccines & …, 2014 - pubmed.ncbi.nlm.nih.gov
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

[PDF][PDF] A Dose-Range Study in Older Adults to Compare the Safety and Immunogenicity Profiles of MF59®-Adjuvanted and Non-Adjuvanted Seasonal Influenza …

G Della Cioppa, U Nicolay, K Lindert, G Leroux-Roels… - core.ac.uk
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - HUMAN VACCINES …, 2014 - biblio.ugent.be
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines …

G Della Cioppa, U Nicolay, K Lindert… - Human Vaccines & …, 2014 - europepmc.org
Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …